2nd Due Diligence for Life Sciences

On-Demand Content | Virtual Event

Speakers

Gwilym Attwell
Gwilym Attwell
Patent Attorney

FISH & RICHARDSON

Markus Decker

Global Head Search &
Evaluation Oncology

SIMCERE PHARMACEUTICAL GROUP

Paul Fehlner
Senior Vice President, Chief Legal Officer and Corporate Secretary

AXCELLA

Mehdi Ganjeizadeh, Ph.D., J.D.

Executive Director
and Head of Gene Therapy IP

SAREPTA THERAPEUTICS

Sabeena Ghazal
Sabeena Ghazal

Due Diligence Specialist and
Third Party Risk Management Champion

NOVARTIS

Samuel Gosselin
Head, Corporate Development

CARE EVERYWHERE GROUP

Scott Kamholz
Scott Kamholz
M.D./Ph.D. Patent Consultant and Former Administrative Patent Judge

INDEPENDENT CONSULTANT

Ravi Kiron
Head of BioPharma External Innovation

EMD SERONO, INC.

David Korn
Vice President of Intellectual Property and Law

PHRMA

Stephan Kutik

IP Lead for Nephrology
and Orphan Drugs

VIFOR PHARMA

Christopher Mortko
Christopher Mortko

Associate Vice President
and Head of Search and Evaluation
in Business Development
and Licensing

MERCK

Ahmed Mousa

Chief Business Officer
General Counsel

PIERIS PHARMACEUTICALS

Dr. Segev Shani

Vice President, Medical &
Regulatory Affairs

NEOPHARM GROUP COMPANIES

Scott Simmons
Scott Simmons

Advisor, External Innovation –
Due Diligence

ELI LILLY

Steven Walker
Director of Alliance management and M&A Integration

ELI LILLY

Lindsey Wanner

Senior Counsel, IP Alliance
and Due Diligence

GILEAD